The increased expression of SDH in patients with HNSCC and poor prognosis conflicts with the reported idea that SDH alteration, dysfunction or mutation is associated with high risk of locoregional recurrence [29]. This evidence concerns the gene SDHB and head and neck squamous cell carcinoma.